Stroke prevention in asymptomatic carotid artery disease : Revascularization of carotid stenosis is not the solution

Polskie Archiwum Medycyny Wewnetrznej

Volumn 125, Issue 5, 2015, Pages 363-369

  Hart, Robert G ^a   Ng, Kuan H ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Asymptomatic carotid stenosis; Carotid artery atherosclerosis; Carotid artery revascularization; Carotid endarterectomy

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DRUG MEGADOSE; HEART MUSCLE REVASCULARIZATION; HIGH RISK POPULATION; HUMAN; INVASIVE PROCEDURE; LOW DRUG DOSE; MASS SCREENING; PATIENT IDENTIFICATION; PRACTICE GUIDELINE; REVIEW; SMOKING CESSATION; TRANSIENT ISCHEMIC ATTACK; TREATMENT PLANNING; ASYMPTOMATIC DISEASE; CAROTID ARTERY; COMPLICATION; DISEASE COURSE; FEMALE; MALE; MIDDLE AGED; PATHOLOGY; RISK ASSESSMENT; STROKE;

ASYMPTOMATIC DISEASES; CAROTID ARTERIES; CAROTID STENOSIS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; STROKE;

EID: 84936862264     PISSN: 00323772     EISSN: 18979483     Source Type: Journal    
DOI: 10.20452/pamw.2838     Document Type: Review

References (62)

1. Fisher M. Occlusion of the internal carotid artery. AMA Arch Neurol Psych. 1951; 65: 346-377.
2. Jonas DE, Feltner C, Amick HR, et al. Screening for asymptomatic carotid artery stenosis: A systematic review and meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2014; 161: 336-346.
3. Abbott AL. Medical (nonsurgical) intervention alone is now best for prevention of stroke associated with asymptomatic severe carotid stenosis. Results of a systematic review and analysis. Stroke. 2009; 40: E573-e583.
4. Raman G, Moorthy D, Hadar N, et al. Management strategies for asymptomatic carotid stenosis. Ann Intern Med. 2013; 158: 676-685.
5. Halliday A, Harrison M, Hayter E, et al. Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): A multicenter randomized trial. Lancet. 2010; 376: 1074-1084.
6. de Weerd M, Grieving JP, Hedblad B, et al. Prediction of asymptomatic carotid artery stenosis in the general population. Identification of high-risk groups. Stroke. 2014; 45: 2366-2371.
7. de Weerd M, Greving JP, de Jong AW, et al. Prevalence of asymptomatic carotid artery stenosis according to age and sex. Stroke. 2009; 40: 1105-1113.
8. Goessen BM, Visseren FL, Kappelle LJ, et al; The SMART Study Group. Asymptomatic carotid artery stenosis and the risk of new vascular events in patients with manifest arterial disease. The SMART study. Stroke. 2007; 38: 1470-1475.
9. Marquardt L, Geraghty OC, Methta Z, Rothwell PM. Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: A prospective, population-based study. Stroke. 2010; 41: E11-e17.
10. Spence JD, Coates C, Li H, et al. Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. Arch Neurol. 2010; 67: 180-186.
11. Naylor AR. What is the current status of invasive treatment of extracranial carotid artery disease? Stroke. 2011; 42: 2080-2085.
12. Sillesen H, Amarenco P, Hennerici MG, et al. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: A secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2008; 39: 3297-3302.
13. Naylor AR. Time to rethink management strategies in asymptomatic carotid artery disease. Nat Rev Cardiol. 2012; 9: 116-124.
14. ACST-2 Collaborative Group; Halliday A, Bulbulia R, Gray W, et al. Status update and interim results from the Asymptomatic Carotid Surgery Trial - 2 (ACST-2). Euro Vasc Endovasc Surg. 2013; 46: 510-518.
15. Das RR, Seshardi S, Beiser AS, et al. Prevalence and correlates of silent cerebral infarcts in the Framingham Offspring Study. Stroke. 2008; 39: 2929-2935.
16. Uehara T, Tabuchi M, Mori E. Risk factors for silent cerebral infarcts in subcortical white matter and basal ganglia. Stroke. 1999; 30: 378-382.
17. Brott T, Tomsick T, Feinberg W, et al; the Asymptomatic Carotid Atherosclerosis Study Investigators. Baseline silent cerebral infarction in the Asymptomatic Carotid Atherosclerosis Study. Stroke. 1994; 25: 1122-1129.
18. Aichner FT, Topakian R, Alberts MJ, et al. High cardiovascular event rates in patients with asymptomatic carotid stenosis: The REACH Registry. Eur J Neurol. 2009; 16: 902-908.
19. Chang X-L, Zhou H-Q, Lei C-Y, et al. Association between asymptomatic carotid stenosis and cognitive function: A systematic review. Neurosci Biobehav Reviews. 2013; 37: 1493-1499.
20. Siddiqui AH, Hopkins LH. Asymptomatic carotid stenosis: The not-so-silent disease. J Am Coll Cardiol. 2013; 61: 2510-2513.
21. Paraskevas KI, Spence JD, Weith FJ, Nicolaides AN. Identifying which patients with asymptomatic carotid stenosis could benefit from intervention. Stroke. 2014; 45: 3720-3724.
22. Spence JD, Pelz D, Veith FJ. Asymptomatic carotid stenosis. Identifying patients at high enough risk to warrant endarterectomy or stenting. Stroke. 2014; 45: 655-657.
23. Nicolaides AN, Kakkos SK, Kyriacou E, et al; the Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group. Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification. J Vasc Surg. 2010; 52: 1486-1496.
24. Kakkos SK, Nicolaides AN, Charalambous I, et al; the Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group. Predictors and clinical significance of progression or regression of asymptomatic carotid stenosis. J Vasc Surg. 2014; 59: 956-967.
25. den Hartog AG, Achterberg S, Moll FL, et al; the SMART Study Group. Asymptomatic carotid artery stenosis and the risk of ischemic stroke 631-636. according to subtype in patients with clinical manifest arterial disease. Stroke. 2013; 44: 1002-1007.
26. Hirt LS. Progression rate and ipsilateral neurological events in asymptomatic carotid stensosis. Stroke. 2014; 45: 702-706.
27. Markus HS, King A, Shipley M, et al. Asymptomatic embolization for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): A prospective observational study. Lancet Neurol. 2010; 9: 663-671.
28. Madani A, Beletsky V, Tamayo A, et al. High-risk asymptomatic carotid stenosis: Ulceration on 3D ultrasound vs. TCD microemboli. Neurol. 2011; 77: 744-750.
29. Partovi S, Loebe M, Aschwanden M, et al. Contrast-enhanced ultrasound for assessing carotid artherosclerotic plaque lesions. AJR Am J Roentgenol. 2012; 198: W13-W19.
30. Kakkos SK, Griffen MB, Nicolaides AN, et al; the Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group. The size of juxtaluminal hypoechoic area in ultrasound images of asymptomatic carotid plaques predicts the occurrence of stroke. J Vasc Surg. 2013; 57: 609-618.
31. Gupta A, Kesavabhotla K, Baradarn H, et al. Plaque echoluncey and stroke risk in asymptomatic carotid stenosis. A systematic review and meta-analysis. Stroke. 2015; 46: 91-97.
32. Pedro LM, Sanchez JM, Seabra J, et al. Asymptomatic carotid disease - A new tool for assessing neurological risk. Echocardiography. 2014; 31: 353-361.
33. Freilinger TM, Schindler A, Schmidt C, et al. Prevalence of nonstenosing, complicated atherosclerotic plaques in cryptogenic stroke. J Am Coll Cardiol Imag. 2012; 5: 397-405.
34. Cai JM, Hatsukami TS, Ferguson MS, et al. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circ. 2002; 106: 1368-1373.
35. Sun J, Balu N, Hippe DS, et al. Subclinical carotid atherosclerosis: Short-term natural history of lipid-rich necrotic core - A multicenter study with MR imaging. Radiol. 2013; 268: 61-88.
36. Underhill HR, Hatsukami TS, Cai J, et al. A noninvasive imaging approach to assess plaque severity: The carotid atherosclerosis score. AJNR Am J Neuroradiolol. 2010; 3: 1068-1075.
37. Xu D, Hippe DS, Underhill HR, et al. Prediction of high-risk plaque development and plaque progression with the Carotid Atherosclerosis Score. J Am Coll Cardiol Img. 2014; 7: 366-373.
38. Kakkos SK, Sabetai M, Tegos T, et al; the Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group. Silent embolic infarcts on computed tomography brain scans and risk of ipsilateral hemispheric events in patients with asymptomatic internal carotid artery stenosis. J Vasc Surg. 2009; 49: 902-909.
39. Muller HFG, Viaccoz A, Fisch L, et al. 18FDG-PET-CT. An imaging biomarker of high-risk carotid plaques, correlation to symptoms and microembolic signals. Stroke. 2014; 45: 3561-3566.
40. Gupta A, Chazen JL, Hartman M, et al. Cerebrovascular reserve and stroke risk in patients with carotid stenosis or occlusion. A systematic review and meta-analysis. Stroke. 2012; 43: 2884-2891.
41. Howard DP, van Lammeren GW, Rothwell PM, et al. Symptomatic carotid atherosclerotic disease. Correlations between plaque composition and ipsilateral stroke risk. Stroke. 2015; 46: 182-189.
42. LeFevre ML, on behalf of the U.S. Preventive Services Task Force. Screening for asymptomatic carotid artery stenosis: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2014; 161: 356-362.
43. den Hartog AG, Bovens SM, Koning W, et al. Current status of clinical magnetic resonance imaging for plaque characteristics in patients with carotid artery stenosis. Euro J Vasc Endovacs Surg. 2013; 45: 7-21.
44. Naylor AR, Schroeder TV, Sillesen H. Clinical and imaging features associated with an increased risk of late stroke in patients with asymptomatic carotid disease. Eur J Vasc Endovasc Surg. 2014; 48: 633-640.
45. European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008; 25: 457-507.
46. Karolinska Stroke Update Consensus Statements 2012. 1. Carotid endarterectomy versus angioplasty and stenting. www.strokeupdate.org/Cons-Carotid-session-2012.aspx. Accessed April 15, 2015.
47. Tendera M, Aboyans V, Bartelink M-L, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases. Eur Heart J. 2011; 32: 2851-2906.
48. NICE interventional procedure guidance 388. Carotid artery stent placement for asymptomatic extracranial carotid stenosis. Guidance 388 (Issued April 2011). www.nice.org.uk/ipg388. Accessed April 15, 2015.
49. Meschia JF, Bushnell C, Boden-Albala B, et al. Guidelines for the primary prevention of stroke. A statement for healthcare professionals from the American Heart Assocation/American Stroke Association. Stroke. 2014; 45: 3754-3832.
50. Coutts SB, Wein TH, Lindsay MP, et al. on behalf of the Heart and Stroke Foundation Canada Canadian Stroke Best Practices Advisory Committee. Canadian Stroke Best Practice Recommendations: Secondary prevention of stroke guidelines, update 2014. Int J Stroke. DOI 10.111/ijs.12 439.
51. Ricotta JJ, AbuRahma A, Ascher E, et al. Updated Society of Vascular Surgery guidelines of management of extracranial carotid disease. Executive summary. J Vasc Surg. 2011; 54: 832-836.
52. Shaneyfelt T. In guidelines we cannot trust. Arch Intern Med. 2012; 172: 1633-1634.
53. Hart RG, Bailey RD. An assessment of guidelines for prevention of ischemic stroke. Neurology 2002; 59: 977-982.
54. Heldenberg E, Bass A. Is there a role for asymptomatic carotid artery stenosis screening? Harefuah. 2014; 153: 475-477.
55. Goldstein LB, Bushnell CD, Adams RJ, et al. American Heart Association Stroke Council Guidelines for the primary prevention of stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011; 42: 517-584.
56. Weyer GW, Davis AM. Screening for asymptomatic carotid artery stenosis. JAMA. 2015; 313: 192-193.
57. Kolos I, Loukianov M, Dupik N, et al. Optimal medical treatment versus carotid endarterectomy: The rationale and design of the Aggressive Medical Treatment Evaluation for Asymptomatic Carotid Artery Stenosis (AMTEC) study. Int J Stroke. 2015; 10: 269-274.
58. Rudarakanchana N, Dialynas M, Halliday A. Asymptomatic Carotid Surgery Trial - 2 (ACST-2): Rationale for a randomized clinical trial comparing carotid endarterectomy with carotid artery stenting in patients with asymptomatic carotid artery stenosis. Eur J Vasc Endovas Surg. 2009; 38: 239-242.
59. Woo K, Garg J, Hye RJ, Dilley RB. Contemporary results of carotid endarterectomy for asymptomatic carotid stenosis. Stroke. 2010; 41: 975-978.
60. Naylor AR. Identifying the high-risk carotid plaque. Journal of Cardiovascular Surgery. 2014; 55:11-20.
61. Ng KH, Oczkowski W. Treatment options for asymptomatic carotid artery stenosis were compared. ACP Journal Club. 2013; 159: 6.
62. Hirt L, Halliday A. Controversies in neurology: Asymptomatic carotid stenosis - intervention or just stick to medical therapy. The argument for carotid endarterectomy. J Neural Trans. 2011; 118: 631-636.